NEW YORK (GenomeWeb News) – Martin Madaus will take the CEO and chairman posts at Ortho Clinical Diagnostics upon the closure of The Carlyle Group's acquisition of OCD from Johnson and Johnson, which is expected to be mid-2014, OCD said this week.

Madaus recently was president, chairman, and CEO of Millipore, and is currently executive chairman of Quanterix's board of directors. He also is a director at Carlyle's portfolio companies PPD, Mettler Toledo, and Covidien.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.